India hosts more active pharmaceutical ingredient (API) manufacturing sites that are compliant with the U.S. Food and Drug Administration than any country outside the U.S., and it produces more ...

When the campus is complete, it will produce several of Lilly’s APIs and genetic medicines to serve US patients.